GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tgif1
|
ENSMUSG00000047407.11 | TGFB-induced factor homeobox 1 |
Meis3
|
ENSMUSG00000041420.12 | Meis homeobox 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Meis3 | mm10_v2_chr7_+_16175275_16175438 | -0.82 | 1.4e-09 | Click! |
Tgif1 | mm10_v2_chr17_-_70853482_70853546 | -0.67 | 8.7e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_97417730 | 14.01 |
ENSMUST00000043077.7
|
Thrsp
|
thyroid hormone responsive |
chr19_+_39287074 | 12.31 |
ENSMUST00000003137.8
|
Cyp2c29
|
cytochrome P450, family 2, subfamily c, polypeptide 29 |
chr11_-_5950018 | 9.31 |
ENSMUST00000102920.3
|
Gck
|
glucokinase |
chr2_+_155517948 | 8.59 |
ENSMUST00000029135.8
ENSMUST00000065973.2 ENSMUST00000103142.5 |
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr5_-_87337165 | 8.53 |
ENSMUST00000031195.2
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr7_-_30924169 | 8.06 |
ENSMUST00000074671.6
|
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr8_+_105083753 | 7.39 |
ENSMUST00000093221.6
ENSMUST00000074403.6 |
Ces3b
|
carboxylesterase 3B |
chr15_-_76126538 | 7.16 |
ENSMUST00000054022.5
ENSMUST00000089654.3 |
BC024139
|
cDNA sequence BC024139 |
chrX_+_10252361 | 7.06 |
ENSMUST00000115528.2
|
Otc
|
ornithine transcarbamylase |
chrX_+_10252305 | 6.74 |
ENSMUST00000049910.6
|
Otc
|
ornithine transcarbamylase |
chr18_-_74961252 | 6.24 |
ENSMUST00000066532.4
|
Lipg
|
lipase, endothelial |
chr15_-_60921270 | 6.16 |
ENSMUST00000096418.3
|
A1bg
|
alpha-1-B glycoprotein |
chr8_+_107150621 | 5.35 |
ENSMUST00000034400.3
|
Cyb5b
|
cytochrome b5 type B |
chr7_-_46742979 | 5.10 |
ENSMUST00000128088.1
|
Saa1
|
serum amyloid A 1 |
chr3_-_81975742 | 4.85 |
ENSMUST00000029645.8
|
Tdo2
|
tryptophan 2,3-dioxygenase |
chr9_+_74953053 | 4.73 |
ENSMUST00000170846.1
|
Fam214a
|
family with sequence similarity 214, member A |
chr2_+_102706356 | 4.67 |
ENSMUST00000123759.1
ENSMUST00000111212.1 ENSMUST00000005220.4 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr10_-_24101951 | 4.64 |
ENSMUST00000170267.1
|
Taar8c
|
trace amine-associated receptor 8C |
chr15_+_6445320 | 4.60 |
ENSMUST00000022749.9
|
C9
|
complement component 9 |
chr19_-_7966000 | 4.42 |
ENSMUST00000182102.1
ENSMUST00000075619.4 |
Slc22a27
|
solute carrier family 22, member 27 |
chr4_-_82705735 | 4.35 |
ENSMUST00000155821.1
|
Nfib
|
nuclear factor I/B |
chr11_+_77518566 | 4.24 |
ENSMUST00000147386.1
|
Abhd15
|
abhydrolase domain containing 15 |
chr1_+_130826676 | 4.19 |
ENSMUST00000027675.7
|
Pigr
|
polymeric immunoglobulin receptor |
chr15_+_10177623 | 4.19 |
ENSMUST00000124470.1
|
Prlr
|
prolactin receptor |
chr1_-_150466165 | 4.08 |
ENSMUST00000162367.1
ENSMUST00000161611.1 ENSMUST00000161320.1 ENSMUST00000159035.1 |
Prg4
|
proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein) |
chr6_-_85869128 | 4.00 |
ENSMUST00000045008.7
|
Cml2
|
camello-like 2 |
chr15_+_10215955 | 3.88 |
ENSMUST00000130720.1
|
Prlr
|
prolactin receptor |
chr10_+_87860030 | 3.84 |
ENSMUST00000062862.6
|
Igf1
|
insulin-like growth factor 1 |
chr1_-_180195981 | 3.82 |
ENSMUST00000027766.6
ENSMUST00000161814.1 |
Adck3
|
aarF domain containing kinase 3 |
chr19_-_8218832 | 3.81 |
ENSMUST00000113298.2
|
Slc22a29
|
solute carrier family 22. member 29 |
chr1_+_167618246 | 3.74 |
ENSMUST00000111380.1
|
Rxrg
|
retinoid X receptor gamma |
chr2_-_86347764 | 3.67 |
ENSMUST00000099894.2
|
Olfr1055
|
olfactory receptor 1055 |
chr11_-_11890368 | 3.65 |
ENSMUST00000155690.1
|
Ddc
|
dopa decarboxylase |
chr2_-_103485068 | 3.61 |
ENSMUST00000111168.3
|
Cat
|
catalase |
chr7_+_46751832 | 3.61 |
ENSMUST00000075982.2
|
Saa2
|
serum amyloid A 2 |
chr4_-_155345696 | 3.58 |
ENSMUST00000103178.4
|
Prkcz
|
protein kinase C, zeta |
chr15_+_9279829 | 3.53 |
ENSMUST00000022861.8
|
Ugt3a1
|
UDP glycosyltransferases 3 family, polypeptide A1 |
chr19_+_3986564 | 3.52 |
ENSMUST00000054030.7
|
Acy3
|
aspartoacylase (aminoacylase) 3 |
chr19_-_8405060 | 3.45 |
ENSMUST00000064507.5
ENSMUST00000120540.1 ENSMUST00000096269.4 |
Slc22a30
|
solute carrier family 22, member 30 |
chr17_+_24804312 | 3.40 |
ENSMUST00000024972.5
|
Meiob
|
meiosis specific with OB domains |
chr10_-_81291227 | 3.35 |
ENSMUST00000045744.6
|
Tjp3
|
tight junction protein 3 |
chr10_+_116301374 | 3.33 |
ENSMUST00000092167.5
|
Ptprb
|
protein tyrosine phosphatase, receptor type, B |
chr19_-_7802578 | 3.27 |
ENSMUST00000120522.1
ENSMUST00000065634.7 |
Slc22a26
|
solute carrier family 22 (organic cation transporter), member 26 |
chr11_+_98348404 | 3.26 |
ENSMUST00000078694.6
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr8_-_67974567 | 3.26 |
ENSMUST00000098696.3
ENSMUST00000038959.9 ENSMUST00000093469.4 |
Psd3
|
pleckstrin and Sec7 domain containing 3 |
chr7_-_99695809 | 3.24 |
ENSMUST00000107086.2
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr1_-_121327672 | 3.22 |
ENSMUST00000159085.1
ENSMUST00000159125.1 ENSMUST00000161818.1 |
Insig2
|
insulin induced gene 2 |
chr8_-_5105232 | 3.17 |
ENSMUST00000023835.1
|
Slc10a2
|
solute carrier family 10, member 2 |
chr8_+_45658666 | 3.07 |
ENSMUST00000134675.1
ENSMUST00000139869.1 ENSMUST00000126067.1 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr3_+_94377505 | 3.07 |
ENSMUST00000098877.2
|
Rorc
|
RAR-related orphan receptor gamma |
chr2_+_71981184 | 3.07 |
ENSMUST00000090826.5
ENSMUST00000102698.3 |
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chrX_+_140664565 | 3.05 |
ENSMUST00000128809.1
|
Mid2
|
midline 2 |
chr10_+_87859593 | 3.02 |
ENSMUST00000126490.1
|
Igf1
|
insulin-like growth factor 1 |
chr2_+_162987330 | 2.96 |
ENSMUST00000018012.7
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr9_+_108692116 | 2.95 |
ENSMUST00000035220.6
|
Prkar2a
|
protein kinase, cAMP dependent regulatory, type II alpha |
chr19_+_38481057 | 2.94 |
ENSMUST00000182481.1
|
Plce1
|
phospholipase C, epsilon 1 |
chrX_-_113185485 | 2.94 |
ENSMUST00000026607.8
ENSMUST00000113388.2 |
Chm
|
choroidermia |
chr15_-_58076456 | 2.93 |
ENSMUST00000070143.6
ENSMUST00000110168.1 |
Zhx1
|
zinc fingers and homeoboxes 1 |
chr4_-_119383732 | 2.93 |
ENSMUST00000044781.2
ENSMUST00000084307.3 |
Ccdc30
|
coiled-coil domain containing 30 |
chr7_-_14492926 | 2.92 |
ENSMUST00000108524.3
|
Sult2a7
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 7 |
chr19_-_20727533 | 2.88 |
ENSMUST00000025656.3
|
Aldh1a7
|
aldehyde dehydrogenase family 1, subfamily A7 |
chr11_-_11890394 | 2.86 |
ENSMUST00000109659.2
|
Ddc
|
dopa decarboxylase |
chr11_-_84167466 | 2.82 |
ENSMUST00000050771.7
|
Gm11437
|
predicted gene 11437 |
chr11_-_72795801 | 2.82 |
ENSMUST00000079681.5
|
Cyb5d2
|
cytochrome b5 domain containing 2 |
chr10_+_128254131 | 2.78 |
ENSMUST00000060782.3
|
Apon
|
apolipoprotein N |
chr1_-_121327734 | 2.71 |
ENSMUST00000160968.1
ENSMUST00000162582.1 |
Insig2
|
insulin induced gene 2 |
chr4_+_148130883 | 2.68 |
ENSMUST00000084129.2
|
Mad2l2
|
MAD2 mitotic arrest deficient-like 2 |
chr10_+_79890853 | 2.66 |
ENSMUST00000061653.7
|
Cfd
|
complement factor D (adipsin) |
chr6_+_125320633 | 2.65 |
ENSMUST00000176655.1
ENSMUST00000176110.1 |
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr2_-_67433181 | 2.64 |
ENSMUST00000180773.1
|
Gm26727
|
predicted gene, 26727 |
chr15_+_44196135 | 2.64 |
ENSMUST00000038856.6
ENSMUST00000110289.3 |
Trhr
|
thyrotropin releasing hormone receptor |
chr7_+_49246131 | 2.63 |
ENSMUST00000064395.6
|
Nav2
|
neuron navigator 2 |
chr14_+_69171576 | 2.62 |
ENSMUST00000062437.8
|
Nkx2-6
|
NK2 homeobox 6 |
chr8_+_76899772 | 2.62 |
ENSMUST00000109913.2
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr1_+_187997835 | 2.61 |
ENSMUST00000110938.1
|
Esrrg
|
estrogen-related receptor gamma |
chrX_+_140664908 | 2.61 |
ENSMUST00000112990.1
ENSMUST00000112988.1 |
Mid2
|
midline 2 |
chr2_-_164857542 | 2.60 |
ENSMUST00000109316.1
ENSMUST00000156255.1 ENSMUST00000128110.1 ENSMUST00000109317.3 |
Pltp
|
phospholipid transfer protein |
chr3_+_94377432 | 2.58 |
ENSMUST00000107292.1
|
Rorc
|
RAR-related orphan receptor gamma |
chr8_+_45658273 | 2.57 |
ENSMUST00000153798.1
|
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr17_+_43953191 | 2.57 |
ENSMUST00000044792.4
|
Rcan2
|
regulator of calcineurin 2 |
chr17_+_43952999 | 2.56 |
ENSMUST00000177857.1
|
Rcan2
|
regulator of calcineurin 2 |
chr6_+_88724489 | 2.56 |
ENSMUST00000113581.1
|
Mgll
|
monoglyceride lipase |
chr18_+_56432116 | 2.56 |
ENSMUST00000070166.5
|
Gramd3
|
GRAM domain containing 3 |
chr14_-_51922773 | 2.51 |
ENSMUST00000089771.2
|
Rnase13
|
ribonuclease, RNase A family, 13 (non-active) |
chr5_-_87092546 | 2.50 |
ENSMUST00000132667.1
ENSMUST00000145617.1 ENSMUST00000094649.4 |
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr13_-_24206281 | 2.49 |
ENSMUST00000123076.1
|
Lrrc16a
|
leucine rich repeat containing 16A |
chr10_+_87859255 | 2.46 |
ENSMUST00000105300.2
|
Igf1
|
insulin-like growth factor 1 |
chr7_+_140845562 | 2.45 |
ENSMUST00000035300.5
|
Scgb1c1
|
secretoglobin, family 1C, member 1 |
chr4_-_96664112 | 2.43 |
ENSMUST00000030299.7
|
Cyp2j5
|
cytochrome P450, family 2, subfamily j, polypeptide 5 |
chr7_-_25539845 | 2.43 |
ENSMUST00000066503.7
ENSMUST00000064862.6 |
Ceacam2
|
carcinoembryonic antigen-related cell adhesion molecule 2 |
chr6_-_85832082 | 2.43 |
ENSMUST00000032073.6
|
Nat8
|
N-acetyltransferase 8 (GCN5-related, putative) |
chr7_-_114562945 | 2.43 |
ENSMUST00000119712.1
ENSMUST00000032908.8 |
Cyp2r1
|
cytochrome P450, family 2, subfamily r, polypeptide 1 |
chr6_+_88724462 | 2.40 |
ENSMUST00000113582.1
|
Mgll
|
monoglyceride lipase |
chr17_-_12940317 | 2.40 |
ENSMUST00000160378.1
ENSMUST00000043923.5 |
Acat3
|
acetyl-Coenzyme A acetyltransferase 3 |
chr9_+_55326913 | 2.40 |
ENSMUST00000085754.3
ENSMUST00000034862.4 |
AI118078
|
expressed sequence AI118078 |
chr1_-_139781236 | 2.39 |
ENSMUST00000027612.8
ENSMUST00000111989.2 ENSMUST00000111986.2 |
Gm4788
|
predicted gene 4788 |
chr11_+_83746940 | 2.39 |
ENSMUST00000070832.2
|
1100001G20Rik
|
RIKEN cDNA 1100001G20 gene |
chr7_+_87246649 | 2.37 |
ENSMUST00000068829.5
ENSMUST00000032781.7 |
Nox4
|
NADPH oxidase 4 |
chr11_+_72435511 | 2.37 |
ENSMUST00000076443.3
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr2_+_72054598 | 2.37 |
ENSMUST00000028525.5
|
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr19_-_57182293 | 2.35 |
ENSMUST00000133369.1
|
Ablim1
|
actin-binding LIM protein 1 |
chr2_+_162987502 | 2.35 |
ENSMUST00000117123.1
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr6_+_88724828 | 2.35 |
ENSMUST00000089449.2
|
Mgll
|
monoglyceride lipase |
chr6_-_138043411 | 2.34 |
ENSMUST00000111873.1
|
Slc15a5
|
solute carrier family 15, member 5 |
chr4_+_102254993 | 2.32 |
ENSMUST00000106908.2
|
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr10_+_87859062 | 2.31 |
ENSMUST00000095360.4
|
Igf1
|
insulin-like growth factor 1 |
chr11_+_72435565 | 2.31 |
ENSMUST00000100903.2
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr3_+_107631322 | 2.28 |
ENSMUST00000106703.1
|
Gm10961
|
predicted gene 10961 |
chr2_-_25461094 | 2.28 |
ENSMUST00000114261.2
|
BC029214
|
cDNA sequence BC029214 |
chr8_-_84800024 | 2.27 |
ENSMUST00000126806.1
ENSMUST00000076715.6 |
Nfix
|
nuclear factor I/X |
chr11_+_72435534 | 2.26 |
ENSMUST00000108499.1
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr7_-_25477607 | 2.26 |
ENSMUST00000098669.1
ENSMUST00000098668.1 ENSMUST00000098666.2 |
Ceacam1
|
carcinoembryonic antigen-related cell adhesion molecule 1 |
chr4_+_115411624 | 2.25 |
ENSMUST00000094887.3
|
Cyp4a12b
|
cytochrome P450, family 4, subfamily a, polypeptide 12B |
chr5_+_65131184 | 2.23 |
ENSMUST00000031089.5
ENSMUST00000101191.3 |
Klhl5
|
kelch-like 5 |
chr3_+_89459325 | 2.23 |
ENSMUST00000107410.1
|
Pmvk
|
phosphomevalonate kinase |
chr8_-_45382198 | 2.22 |
ENSMUST00000093526.6
|
Fam149a
|
family with sequence similarity 149, member A |
chr1_+_93235836 | 2.21 |
ENSMUST00000062202.7
|
Sned1
|
sushi, nidogen and EGF-like domains 1 |
chr8_+_104926237 | 2.20 |
ENSMUST00000034355.4
ENSMUST00000109410.2 |
Ces2e
|
carboxylesterase 2E |
chr6_+_88724667 | 2.18 |
ENSMUST00000163271.1
|
Mgll
|
monoglyceride lipase |
chr1_+_88095054 | 2.18 |
ENSMUST00000150634.1
ENSMUST00000058237.7 |
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C |
chr7_-_48848023 | 2.17 |
ENSMUST00000032658.6
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr8_+_88697022 | 2.17 |
ENSMUST00000043526.8
|
Cyld
|
cylindromatosis (turban tumor syndrome) |
chr17_-_34305715 | 2.16 |
ENSMUST00000174074.1
|
Gm20513
|
predicted gene 20513 |
chr11_-_5915124 | 2.15 |
ENSMUST00000109823.2
ENSMUST00000109822.1 |
Gck
|
glucokinase |
chr7_-_45136102 | 2.14 |
ENSMUST00000125500.1
|
Flt3l
|
FMS-like tyrosine kinase 3 ligand |
chr2_-_25500613 | 2.13 |
ENSMUST00000040042.4
|
C8g
|
complement component 8, gamma polypeptide |
chr2_-_73386396 | 2.10 |
ENSMUST00000112044.1
ENSMUST00000112043.1 ENSMUST00000076463.5 |
Gpr155
|
G protein-coupled receptor 155 |
chr4_+_41760454 | 2.10 |
ENSMUST00000108040.1
|
Il11ra1
|
interleukin 11 receptor, alpha chain 1 |
chr6_-_85915604 | 2.09 |
ENSMUST00000174369.1
|
Cml1
|
camello-like 1 |
chr3_-_88425094 | 2.09 |
ENSMUST00000168755.1
ENSMUST00000057935.6 |
Slc25a44
|
solute carrier family 25, member 44 |
chr18_-_39490649 | 2.07 |
ENSMUST00000115567.1
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr10_+_62920648 | 2.05 |
ENSMUST00000144459.1
|
Slc25a16
|
solute carrier family 25 (mitochondrial carrier, Graves disease autoantigen), member 16 |
chr15_+_23036449 | 2.05 |
ENSMUST00000164787.1
|
Cdh18
|
cadherin 18 |
chr16_+_13940630 | 2.05 |
ENSMUST00000141971.1
ENSMUST00000124947.1 ENSMUST00000023360.7 ENSMUST00000143697.1 |
Mpv17l
|
Mpv17 transgene, kidney disease mutant-like |
chr9_+_77921908 | 2.05 |
ENSMUST00000133757.1
|
Elovl5
|
ELOVL family member 5, elongation of long chain fatty acids (yeast) |
chr15_-_8519953 | 2.04 |
ENSMUST00000179217.1
|
Gm2310
|
predicted gene 2310 |
chr3_-_89393629 | 2.03 |
ENSMUST00000124783.1
ENSMUST00000126027.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr19_+_12633303 | 2.02 |
ENSMUST00000044976.5
|
Glyat
|
glycine-N-acyltransferase |
chr2_+_31887262 | 2.02 |
ENSMUST00000138325.1
ENSMUST00000028187.6 |
Lamc3
|
laminin gamma 3 |
chr8_+_45627709 | 2.01 |
ENSMUST00000134321.1
ENSMUST00000135336.1 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr7_-_45136056 | 2.01 |
ENSMUST00000130628.1
|
Flt3l
|
FMS-like tyrosine kinase 3 ligand |
chr8_-_117673682 | 2.01 |
ENSMUST00000173522.1
ENSMUST00000174450.1 |
Sdr42e1
|
short chain dehydrogenase/reductase family 42E, member 1 |
chr10_+_62920630 | 2.00 |
ENSMUST00000044977.3
|
Slc25a16
|
solute carrier family 25 (mitochondrial carrier, Graves disease autoantigen), member 16 |
chrX_-_60403947 | 2.00 |
ENSMUST00000033480.6
ENSMUST00000101527.2 |
Atp11c
|
ATPase, class VI, type 11C |
chr13_-_47043116 | 1.98 |
ENSMUST00000110118.1
ENSMUST00000124948.1 ENSMUST00000021806.3 ENSMUST00000136864.1 |
Tpmt
|
thiopurine methyltransferase |
chr5_-_51553896 | 1.98 |
ENSMUST00000132734.1
|
Ppargc1a
|
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
chr14_-_31640878 | 1.98 |
ENSMUST00000167066.1
ENSMUST00000127204.2 ENSMUST00000022437.8 |
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr19_+_12633507 | 1.97 |
ENSMUST00000119960.1
|
Glyat
|
glycine-N-acyltransferase |
chr13_-_92131494 | 1.97 |
ENSMUST00000099326.3
ENSMUST00000146492.1 |
Rasgrf2
|
RAS protein-specific guanine nucleotide-releasing factor 2 |
chr10_-_83337440 | 1.96 |
ENSMUST00000126617.1
|
Slc41a2
|
solute carrier family 41, member 2 |
chr2_-_160872552 | 1.95 |
ENSMUST00000103111.2
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr15_+_7129557 | 1.95 |
ENSMUST00000067190.5
ENSMUST00000164529.1 |
Lifr
|
leukemia inhibitory factor receptor |
chr8_-_41041828 | 1.95 |
ENSMUST00000051379.7
|
Mtus1
|
mitochondrial tumor suppressor 1 |
chr2_-_164857671 | 1.94 |
ENSMUST00000059954.7
|
Pltp
|
phospholipid transfer protein |
chr4_+_138967112 | 1.94 |
ENSMUST00000116094.2
|
Rnf186
|
ring finger protein 186 |
chr10_+_107271827 | 1.93 |
ENSMUST00000020057.8
ENSMUST00000105280.3 |
Lin7a
|
lin-7 homolog A (C. elegans) |
chr3_+_146597077 | 1.93 |
ENSMUST00000029837.7
ENSMUST00000121133.1 |
Uox
|
urate oxidase |
chr2_-_77519565 | 1.92 |
ENSMUST00000111830.2
|
Zfp385b
|
zinc finger protein 385B |
chr1_+_88087802 | 1.92 |
ENSMUST00000113139.1
|
Ugt1a8
|
UDP glucuronosyltransferase 1 family, polypeptide A8 |
chr5_+_137981512 | 1.92 |
ENSMUST00000035390.5
|
Azgp1
|
alpha-2-glycoprotein 1, zinc |
chr17_+_50509518 | 1.91 |
ENSMUST00000043938.6
|
Plcl2
|
phospholipase C-like 2 |
chr1_+_187997821 | 1.90 |
ENSMUST00000027906.6
|
Esrrg
|
estrogen-related receptor gamma |
chr7_-_126584578 | 1.90 |
ENSMUST00000150311.1
|
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chrX_-_75843063 | 1.90 |
ENSMUST00000114057.1
|
Pls3
|
plastin 3 (T-isoform) |
chr19_+_26605106 | 1.89 |
ENSMUST00000025862.7
ENSMUST00000176030.1 |
Smarca2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr9_-_9239019 | 1.89 |
ENSMUST00000183182.1
|
Arhgap42
|
Rho GTPase activating protein 42 |
chr2_-_27246814 | 1.89 |
ENSMUST00000149733.1
|
Sardh
|
sarcosine dehydrogenase |
chr19_+_5878622 | 1.89 |
ENSMUST00000136833.1
ENSMUST00000141362.1 |
Slc25a45
|
solute carrier family 25, member 45 |
chr2_-_39065505 | 1.88 |
ENSMUST00000039165.8
|
Golga1
|
golgi autoantigen, golgin subfamily a, 1 |
chr2_+_43555321 | 1.88 |
ENSMUST00000028223.2
|
Kynu
|
kynureninase (L-kynurenine hydrolase) |
chr10_+_63024315 | 1.88 |
ENSMUST00000124784.1
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr17_-_24209377 | 1.87 |
ENSMUST00000024931.4
|
Ntn3
|
netrin 3 |
chr3_+_89459118 | 1.86 |
ENSMUST00000029564.5
|
Pmvk
|
phosphomevalonate kinase |
chr11_-_50931612 | 1.84 |
ENSMUST00000109124.3
|
Zfp354b
|
zinc finger protein 354B |
chr6_+_115675983 | 1.84 |
ENSMUST00000068960.9
|
D830050J10Rik
|
RIKEN cDNA D830050J10 gene |
chr4_+_141239499 | 1.84 |
ENSMUST00000141834.2
|
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr1_-_180195902 | 1.83 |
ENSMUST00000161746.1
|
Adck3
|
aarF domain containing kinase 3 |
chr7_+_131410601 | 1.83 |
ENSMUST00000015829.7
ENSMUST00000117518.1 |
Acadsb
|
acyl-Coenzyme A dehydrogenase, short/branched chain |
chr6_+_125321205 | 1.82 |
ENSMUST00000176365.1
|
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chrX_+_59999436 | 1.82 |
ENSMUST00000033477.4
|
F9
|
coagulation factor IX |
chr7_-_101845300 | 1.81 |
ENSMUST00000094141.5
|
Folr2
|
folate receptor 2 (fetal) |
chr4_-_84546284 | 1.81 |
ENSMUST00000177040.1
|
Bnc2
|
basonuclin 2 |
chr13_+_46669517 | 1.81 |
ENSMUST00000099547.3
|
C78339
|
expressed sequence C78339 |
chr5_+_92137896 | 1.80 |
ENSMUST00000031355.6
|
Uso1
|
USO1 vesicle docking factor |
chr11_+_99873389 | 1.79 |
ENSMUST00000093936.3
|
Krtap9-1
|
keratin associated protein 9-1 |
chr15_-_100599864 | 1.79 |
ENSMUST00000177247.2
ENSMUST00000177505.2 |
Pou6f1
|
POU domain, class 6, transcription factor 1 |
chrX_+_57212110 | 1.79 |
ENSMUST00000033466.1
|
Cd40lg
|
CD40 ligand |
chr19_+_32757497 | 1.77 |
ENSMUST00000013807.7
|
Pten
|
phosphatase and tensin homolog |
chr14_+_123659971 | 1.76 |
ENSMUST00000049681.7
|
Itgbl1
|
integrin, beta-like 1 |
chr8_+_85492568 | 1.76 |
ENSMUST00000034136.5
|
Gpt2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
chr2_+_43555342 | 1.76 |
ENSMUST00000112826.1
ENSMUST00000050511.6 |
Kynu
|
kynureninase (L-kynurenine hydrolase) |
chr1_-_136960427 | 1.75 |
ENSMUST00000027649.7
|
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr12_+_104115970 | 1.74 |
ENSMUST00000021496.7
|
Serpina3a
|
serine (or cysteine) peptidase inhibitor, clade A, member 3A |
chr1_-_162898484 | 1.72 |
ENSMUST00000143123.1
|
Fmo2
|
flavin containing monooxygenase 2 |
chr8_+_109990430 | 1.72 |
ENSMUST00000001720.7
ENSMUST00000143741.1 |
Tat
|
tyrosine aminotransferase |
chr2_-_103485138 | 1.72 |
ENSMUST00000028610.3
|
Cat
|
catalase |
chr9_-_9239052 | 1.71 |
ENSMUST00000093893.5
|
Arhgap42
|
Rho GTPase activating protein 42 |
chr6_+_125321409 | 1.71 |
ENSMUST00000176442.1
ENSMUST00000177329.1 |
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chrX_+_139800795 | 1.71 |
ENSMUST00000054889.3
|
Cldn2
|
claudin 2 |
chr9_+_59589288 | 1.71 |
ENSMUST00000121266.1
ENSMUST00000118164.1 |
Celf6
|
CUGBP, Elav-like family member 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.8 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
2.8 | 8.5 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
2.5 | 12.6 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
2.2 | 8.6 | GO:0034757 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
1.9 | 11.6 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
1.8 | 7.3 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
1.7 | 10.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.6 | 6.4 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
1.5 | 10.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.3 | 8.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.3 | 4.0 | GO:0006657 | CDP-choline pathway(GO:0006657) |
1.2 | 3.6 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
1.1 | 4.4 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
1.1 | 4.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.1 | 4.3 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
1.1 | 4.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.0 | 4.2 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
1.0 | 17.5 | GO:0052695 | cellular glucuronidation(GO:0052695) |
1.0 | 13.9 | GO:0015747 | urate transport(GO:0015747) |
1.0 | 4.9 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.9 | 4.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.9 | 3.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.9 | 5.4 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.9 | 3.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.9 | 6.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.9 | 2.6 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.8 | 11.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.8 | 2.4 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.8 | 3.2 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.8 | 2.4 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
0.8 | 2.4 | GO:0070342 | brown fat cell proliferation(GO:0070342) regulation of brown fat cell proliferation(GO:0070347) |
0.8 | 3.2 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.8 | 2.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.7 | 3.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.7 | 2.2 | GO:1903918 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
0.7 | 3.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.7 | 2.1 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.7 | 2.0 | GO:0072343 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.7 | 2.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.6 | 3.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.6 | 1.9 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.6 | 2.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.6 | 1.8 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.6 | 1.2 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.6 | 1.8 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.6 | 1.8 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.6 | 2.9 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.6 | 6.3 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.6 | 2.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.6 | 4.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 2.3 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.6 | 18.2 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.6 | 5.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.6 | 5.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.5 | 2.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.5 | 3.8 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.5 | 2.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.5 | 1.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.5 | 2.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 0.5 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.5 | 2.5 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.5 | 2.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 1.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.5 | 1.5 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.5 | 2.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.5 | 1.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 5.8 | GO:0009650 | UV protection(GO:0009650) |
0.5 | 2.9 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.5 | 3.3 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.5 | 1.4 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.5 | 1.4 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.5 | 2.3 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.5 | 1.4 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.5 | 1.4 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.4 | 1.3 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.4 | 1.8 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.4 | 1.3 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.4 | 8.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 1.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 0.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 1.3 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.4 | 1.3 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
0.4 | 3.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 2.9 | GO:0015862 | uridine transport(GO:0015862) |
0.4 | 1.2 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.4 | 2.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 1.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.4 | 2.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.4 | 1.2 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.4 | 1.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.4 | 1.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.4 | 1.6 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 12.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.4 | 1.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.4 | 1.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 1.2 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.4 | 1.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.4 | 2.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 1.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 0.7 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.4 | 0.4 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.3 | 1.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.3 | 2.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.3 | 2.8 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 1.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.3 | 1.0 | GO:0035603 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) |
0.3 | 0.3 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.3 | 1.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 3.1 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.3 | 4.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 1.4 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.3 | 3.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 1.4 | GO:0048294 | regulation of memory T cell differentiation(GO:0043380) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 2.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.3 | 3.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.3 | 1.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.3 | 1.0 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 1.3 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.3 | 0.3 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.3 | 1.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.3 | 4.0 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.3 | 0.9 | GO:0061552 | vestibulocochlear nerve structural organization(GO:0021649) cell migration involved in vasculogenesis(GO:0035441) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
0.3 | 1.8 | GO:0071484 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.3 | 3.5 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.3 | 2.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 0.9 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.3 | 1.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 1.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 1.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.3 | 1.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 0.6 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.3 | 1.1 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
0.3 | 0.6 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.3 | 1.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 2.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.3 | 5.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.8 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
0.3 | 3.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 1.1 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 0.5 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.3 | 0.8 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.3 | 1.6 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.3 | 1.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 5.0 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.3 | 2.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.3 | 7.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 2.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 0.8 | GO:0042197 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.2 | 1.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 1.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.7 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.2 | 1.5 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 6.8 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.2 | 1.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.9 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.2 | 3.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.5 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.2 | 0.9 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.9 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.2 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.2 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.2 | 2.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 1.8 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 0.9 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.2 | 0.7 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.2 | 2.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 1.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 3.8 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.2 | 0.9 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.7 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.2 | 0.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) regulation of vitamin A metabolic process(GO:1901738) |
0.2 | 1.1 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.2 | 0.2 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.2 | 0.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.6 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 9.0 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 0.6 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.2 | 1.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 1.0 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 1.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.2 | 2.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 10.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 0.6 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 3.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 2.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 0.6 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.2 | 3.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.2 | 0.6 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.2 | 0.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 0.6 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.2 | 1.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 1.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 0.2 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.2 | 1.4 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.2 | 1.6 | GO:0009313 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.6 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.2 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 1.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.6 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.2 | 2.3 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 0.6 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.6 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.2 | 1.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 3.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 1.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 1.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 2.2 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.9 | GO:0003322 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.2 | 2.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.4 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.2 | 0.9 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.2 | 0.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 0.6 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.2 | 0.4 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.2 | 1.1 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.2 | 0.9 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.2 | 1.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 1.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 1.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.2 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 1.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.9 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.2 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.7 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 1.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.9 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 0.8 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 1.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.8 | GO:0014042 | positive regulation of mitochondrial fusion(GO:0010636) positive regulation of neuron maturation(GO:0014042) |
0.2 | 3.1 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 0.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.2 | 0.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 1.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.5 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 1.0 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 3.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 0.5 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 0.6 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.2 | 0.5 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.2 | 0.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 1.9 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.5 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
0.2 | 0.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 2.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 2.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 1.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 0.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 1.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 6.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 1.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 1.0 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
0.1 | 0.4 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.1 | 0.6 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 1.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.4 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.1 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 2.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 3.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 2.0 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 0.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 1.7 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.3 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.4 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.1 | 0.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 3.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 3.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.4 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.1 | 1.0 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.1 | 0.4 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.4 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.7 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 5.6 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.7 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.1 | 1.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.5 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 2.1 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 1.4 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.5 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.5 | GO:0030026 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.1 | 0.3 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.3 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.1 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.1 | 1.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.7 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 1.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 1.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 2.1 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 1.4 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.1 | 1.0 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.2 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 1.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.7 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 1.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 1.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.6 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.1 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 3.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 1.8 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 0.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.5 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 3.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.8 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 1.1 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.1 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.1 | 0.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.2 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.1 | 0.3 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 | 0.6 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.3 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) negative regulation of histone phosphorylation(GO:0033128) |
0.1 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 1.3 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.1 | 0.7 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.4 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 1.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.8 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.4 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.8 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.6 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.4 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.1 | 0.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.6 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 1.0 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 1.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 3.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 1.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.4 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.1 | 0.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 1.6 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.8 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.8 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.1 | 0.8 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.4 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 0.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 1.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 1.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 1.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.4 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.1 | 0.5 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.1 | 0.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 1.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.9 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.6 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 1.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 2.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 1.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.3 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.1 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0033505 | ventral midline development(GO:0007418) floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
0.1 | 0.3 | GO:2000812 | response to rapamycin(GO:1901355) regulation of barbed-end actin filament capping(GO:2000812) |
0.1 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 1.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 4.5 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.3 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.1 | 1.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 1.6 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.3 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 1.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 1.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 3.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.4 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 1.6 | GO:0015918 | sterol transport(GO:0015918) |
0.1 | 0.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.4 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.8 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 1.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.3 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.1 | 0.2 | GO:0002352 | B cell negative selection(GO:0002352) |
0.1 | 0.4 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 1.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 1.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.5 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.9 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.4 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.2 | GO:0099552 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.1 | 0.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.6 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 1.0 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 2.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 0.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 1.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.4 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 2.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.1 | 4.1 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.4 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) ferrous iron import(GO:0070627) |
0.1 | 1.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.7 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 3.5 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.6 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.3 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 0.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.3 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.1 | 0.9 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 1.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 2.1 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.6 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 2.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 4.3 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.5 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.2 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 0.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.2 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.1 | 0.6 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 2.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.8 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.5 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.2 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.1 | 0.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 3.0 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 1.0 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.4 | GO:0043585 | nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) |
0.1 | 0.7 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.9 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.3 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 0.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.5 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.5 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.4 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.8 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.1 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.2 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.4 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 1.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.1 | 2.4 | GO:0032835 | glomerulus development(GO:0032835) |
0.1 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.7 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.6 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 1.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.5 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.2 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.1 | 0.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.8 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.0 | 0.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.0 | 1.8 | GO:1902652 | cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
0.0 | 0.1 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.0 | 1.9 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.1 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
0.0 | 0.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.8 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 1.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.7 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.7 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 |